Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin
- 529 Downloads
Functional inactivation of HFE or hemojuvelin (HJV) is causatively linked to adult or juvenile hereditary hemochromatosis, respectively. Systemic iron overload results from inadequate expression of hepcidin, the iron regulatory hormone. While HJV regulates hepcidin by amplifying bone morphogenetic protein (BMP) signaling, the role of HFE in the hepcidin pathway remains incompletely understood. We investigated the pathophysiological implications of combined Hfe and Hjv ablation in mice. Isogenic Hfe −/− and Hjv −/− mice were crossed to generate double Hfe −/− Hjv −/− progeny. Wild-type control and mutant mice of all genotypes were analyzed for serum, hepatic, and splenic iron content, expression of iron metabolism proteins, and expression of hepcidin and Smad signaling in the liver, in response to a standard or an iron-enriched diet. As expected, Hfe −/− and Hjv −/− mice developed relatively mild or severe iron overload, respectively, which corresponded to the degree of hepcidin inhibition. The double Hfe −/− Hjv −/− mice exhibited an indistinguishable phenotype to single Hjv −/− counterparts with regard to suppression of hepcidin, serum and hepatic iron overload, splenic iron deficiency, tissue iron metabolism, and Smad signaling, under both dietary regimens. We conclude that the hemochromatotic phenotype caused by disruption of Hjv is not further aggravated by combined Hfe/Hjv deficiency. Our results provide genetic evidence that Hfe and Hjv operate in the same pathway for the regulation of hepcidin expression and iron metabolism.
Combined disruption of Hfe and Hjv phenocopies single Hjv deficiency.
Single Hjv−/− and double Hfe−/−Hjv−/− mice exhibit comparable iron overload.
Hfe and Hjv regulate hepcidin via the same pathway.
KeywordsHemochromatosis Iron overload BMP/SMAD
This work was supported by a grant from the Canadian Institutes for Health Research (MOP-86514). KP and MMS were recipients of Chercheur National and Chercheur Senior career awards, respectively, from the Fonds de la Recherche en Santé du Quebéc (FRSQ). KG was supported by doctoral awards from the J. Latsis and A. Onassis Public Benefit Foundations and from FRSQ.
The authors declare no competing financial interests.
- 11.Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A 95:1472–1477CrossRefPubMedCentralPubMedGoogle Scholar
- 28.Fleming RE, Holden CC, Tomatsu S, Waheed A, Brunt EM, Britton RS, Bacon BR, Roopenian DC, Sly WS (2001) Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc Natl Acad Sci U S A 98:2707–2711CrossRefPubMedCentralPubMedGoogle Scholar
- 32.Poli M, Luscieti S, Gandini V, Maccarinelli F, Finazzi D, Silvestri L, Roetto A, Arosio P (2010) Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation. Haematologica 95:1832–1840CrossRefPubMedCentralPubMedGoogle Scholar
- 33.Ramey G, Deschemin JC, Vaulont S (2009) Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes. Haematologica 94:765–772CrossRefPubMedCentralPubMedGoogle Scholar